Neeraj Agarwal Selected Research

Neeraj Agarwal Research Topics

Disease

158	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 07/2007
140	Neoplasms (Cancer) 05/2024 - 04/2007
93	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 06/2010
53	Neoplasm Metastasis (Metastasis) 05/2024 - 08/2007
43	Carcinoma (Carcinomatosis) 05/2024 - 06/2009
30	Disease Progression 04/2024 - 05/2010
26	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 06/2009
20	Fatigue 04/2024 - 11/2012
13	Pain (Aches) 12/2023 - 08/2013
10	Kidney Neoplasms (Kidney Cancer) 04/2024 - 01/2015
10	COVID-19 01/2023 - 01/2020
10	Glaucoma 11/2008 - 04/2002
7	Circulating Neoplastic Cells 12/2023 - 04/2014
6	Breast Neoplasms (Breast Cancer) 03/2024 - 02/2002
6	Anemia 12/2023 - 01/2009
6	Hypertension (High Blood Pressure) 01/2023 - 05/2010
5	Non-Muscle Invasive Bladder Neoplasms 01/2024 - 01/2017
5	Exanthema (Rash) 01/2022 - 05/2010
4	Melanoma (Melanoma, Malignant) 09/2022 - 03/2014
4	Ganglion Cysts (Ganglion) 02/2007 - 11/2002
3	Adenocarcinoma 05/2024 - 10/2019
3	Inflammation (Inflammations) 05/2024 - 01/2009
3	Infections 09/2022 - 01/2020
3	Drug-Related Side Effects and Adverse Reactions 07/2022 - 03/2014
3	Nausea 01/2022 - 03/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020 - 04/2008

Drug/Important Bio-Agent (IBA)

48	AndrogensIBA 05/2024 - 05/2010
38	Immune Checkpoint InhibitorsIBA 04/2024 - 12/2016
31	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2015
27	Androgen Receptors (Androgen Receptor)IBA 04/2024 - 01/2013
25	enzalutamideIBA 01/2024 - 05/2012
21	Hormones (Hormone)IBA 04/2024 - 12/2013
19	Docetaxel (Taxotere)FDA Link 04/2024 - 01/2011
19	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 01/2020
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 09/2012
17	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2010
16	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 12/2011
15	apalutamideIBA 04/2024 - 01/2019
14	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2024 - 01/2020
14	PlatinumIBA 01/2024 - 01/2017
13	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 08/2013
13	abirateroneIBA 11/2023 - 01/2017
13	Circulating Tumor DNAIBA 01/2023 - 05/2017
11	cabozantinibIBA 04/2024 - 07/2016
10	Cell-Free Nucleic AcidsIBA 12/2023 - 01/2018
10	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 08/2007
10	Sunitinib (Sutent)FDA Link 01/2021 - 06/2010
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2002
9	olaparibIBA 11/2023 - 01/2018
9	Interleukin-2 (IL2)IBA 01/2019 - 03/2014
8	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2011
8	Abiraterone AcetateIBA 01/2019 - 05/2010
7	Messenger RNA (mRNA)IBA 05/2024 - 04/2002
7	Radium-223IBA 01/2022 - 05/2012
7	sipuleucel-T (APC8015)FDA Link 02/2021 - 08/2011
6	LigandsIBA 04/2024 - 04/2004
6	pazopanib FDA Link 03/2024 - 02/2015
6	bicalutamide (Casodex)FDA LinkGeneric 03/2024 - 05/2015
6	talazoparibIBA 01/2024 - 02/2022
6	Everolimus FDA Link 01/2023 - 02/2014
6	VaccinesIBA 09/2022 - 08/2011
5	orteronelIBA 03/2024 - 03/2015
5	rucaparibIBA 03/2024 - 01/2020
5	Gemcitabine FDA Link 02/2024 - 09/2013
5	pembrolizumabIBA 01/2024 - 01/2017
5	taxaneIBA 12/2023 - 01/2019
5	atezolizumabIBA 03/2022 - 01/2017
5	Monoclonal AntibodiesIBA 02/2021 - 01/2015
5	IpilimumabIBA 01/2021 - 01/2013
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 06/2015
4	AntigensIBA 04/2024 - 03/2004
4	Hemoglobins (Hemoglobin)IBA 04/2024 - 01/2007
4	Alkaline PhosphataseIBA 02/2024 - 04/2014
4	B7-H1 AntigenIBA 01/2024 - 01/2021
4	avelumabIBA 10/2023 - 10/2017
4	EnzymesIBA 10/2022 - 02/2002
4	Axitinib (AG 013736)IBA 01/2021 - 02/2015
4	MTOR InhibitorsIBA 01/2018 - 02/2014
3	AntibodiesIBA 04/2024 - 04/2015
3	NivolumabIBA 02/2024 - 10/2017
3	sacituzumab govitecanIBA 01/2024 - 01/2021
3	insulin receptor-related receptor (IRR)IBA 01/2023 - 02/2014
3	IronIBA 10/2022 - 10/2008
3	Phosphotransferases (Kinase)IBA 09/2022 - 01/2017
3	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2022 - 04/2015
3	COVID-19 VaccinesIBA 09/2022 - 01/2021
3	Programmed Cell Death 1 ReceptorIBA 02/2021 - 10/2020

Therapy/Procedure

183	Therapeutics 05/2024 - 01/2005
112	Castration 05/2024 - 05/2010
41	Drug Therapy (Chemotherapy) 01/2024 - 06/2009
35	Immunotherapy 04/2024 - 08/2011
13	Radiotherapy 12/2023 - 12/2011
10	Nephrectomy 01/2023 - 10/2013
7	Cystectomy 12/2020 - 08/2015
6	Neoadjuvant Therapy 10/2020 - 06/2009
5	Adjuvant Chemotherapy 12/2020 - 03/2016
4	Aftercare (After-Treatment) 05/2024 - 04/2008
3	Prostatectomy (Retropubic Prostatectomy) 12/2023 - 12/2018
3	Drug Tapering 01/2023 - 06/2015
3	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 06/2009